Literature DB >> 22382484

Pharmacist's role in a Parkinson's disease and movement disorders clinic.

Linda H Poon1, Audrey J Lee, Teresa B Chiao, Gail A Kang, Susan Heath, Graham A Glass.   

Abstract

PURPOSE: The expanding role of a clinical pharmacist at a Veterans Affairs (VA) out-patient clinic for patients with Parkinson's disease (PD) and movement disorders is described.
SUMMARY: San Francisco VA Medical Center added a clinical pharmacist to the multi-disciplinary team serving patients at an outpatient clinic operated by its Parkinson's Disease Research, Education and Clinical Center (PADRECC). During the first six months after joining the clinic team, the pharmacist met with 131 patients and made a total of 69 drug therapy recommendations that were implemented by neurologists, clinical nurse specialists, and other PADRECC providers. The results of a retrospective chart review suggested that in about 21% of the cases evaluated, the pharmacist's recommendations contributed to an improved medical outcome or the resolution of a medical problem. Anonymous surveys indicated that clinic providers (n = 33) and patients (n = 20) were satisfied with the pharmacist's services. Using a five-point Likert scale (scores ranged from 1 for "strongly disagree" to 5 for "strongly agree") that they had more time to devote to other clinic responsibilities with the pharmacist present in the clinic (mean score, 4.79); patients indicated that they had an improved understanding of their medications after speaking with the pharmacist (mean score, 4.88).
CONCLUSION: A clinical pharmacist's regular involvement in an outpatient PD and movement disorders clinic has been well received by patients and clinic providers. The study results suggest that the pharmacist has made important contributions in areas such as therapeutic problem solving and medication education while freeing up providers for other responsibilities.

Entities:  

Mesh:

Year:  2012        PMID: 22382484     DOI: 10.2146/ajhp110127

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  5 in total

1.  Medication Therapy Management Service for Patients with Parkinson's Disease: A Before-and-After Study.

Authors:  Aline Aparecida Foppa; Clarice Chemello; Claudia Marcela Vargas-Peláez; Mareni Rocha Farias
Journal:  Neurol Ther       Date:  2016-06-07

2.  Implementation and evaluation of Parkinson disease management in an outpatient clinical pharmacist-run neurology telephone clinic.

Authors:  Teodora Cristina Stefan; Nicole Elharar; Guadalupe Garcia
Journal:  Ment Health Clin       Date:  2018-04-26

3.  Specialty pharmacist integration into an outpatient neurology clinic improves pimavanserin access.

Authors:  Sabrina Livezey; Nisha B Shah; Robert McCormick; Josh DeClercq; Leena Choi; Autumn D Zuckerman
Journal:  Ment Health Clin       Date:  2021-05-12

4.  Impact of a Collaborative Pharmaceutical Care Service for Patients With Parkinson's Disease.

Authors:  Zhan-Miao Yi; Sarah Willis; Yuan Zhang; Na Liu; Qi-Yu Tang; Suo-Di Zhai
Journal:  Front Pharmacol       Date:  2022-01-03       Impact factor: 5.810

5.  A qualitative exploration of the healthcare challenges and pharmaceutical care needs of people with Parkinson's and their caregivers.

Authors:  Sabrina Anne Jacob; Zhi Jean Wong; Wing Loong Cheong; Elizabeth Yie-Chuen Chong; Yin Xuan Wong; Sara Lai Heong Lew
Journal:  Int J Clin Pharm       Date:  2021-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.